Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines by Aileen Ebenig, Mona V. Lange, Michael D. Mühlebach

Get full text

Protocol to dissociate healthy and infected murine- and hamster-derived lung tissue for single-cell transcriptome analysis by Peter Pennitz, Cengiz Goekeri, Jakob Trimpert, Emanuel Wyler, Aileen Ebenig, Chantal Weissfuss, Michael D. Mühlebach, Martin Witzenrath, Geraldine Nouailles

Get full text

A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9 by Cindy Hörner, Anna H. Fiedler, Bianca S. Bodmer, Lisa Walz, Vivian A. Scheuplein, Stefan Hutzler, Mikhail N. Matrosovich, Veronika von Messling, Michael D. Mühlebach

Get full text

Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies by Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E. Engeland, Henry Fechner, Karsten Geletneky, Katrin Goepfert, Per Sonne Holm, Stefan Kochanek, Florian Kreppel, Lea Krutzke, Florian Kühnel, Karl Sebastian Lang, Antonio Marchini, Markus Moehler, Michael D. Mühlebach, Ulrike Naumann, Roman Nawroth, Jürg Nüesch, Jean Rommelaere, Ulrich M. Lauer, Guy Ungerechts

Get full text